Search research articles
Contact Us
Filters
Showing results (231-240 of 241) with videos related to
Page
of 25
Sort By:
Clinical Pharmacology and Therapeutics
|
May 28, 2020
How to Transition from Single-Gene Pharmacogenetic Testing to Preemptive Panel-Based Testing: A Tutorial
Richard J Marrero, Emily J Cicali, Meghan J Arwood, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
January 24, 2019
CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trial
D Max Smith, Kristin W Weitzel, Amanda R Elsey, et al.
Genetics & Epigenetics
|
October 30, 2015
Csf2 and Ptgs2 Epigenetic Dysregulation in Diabetes-prone Bicongenic B6.NODC11bxC1tb Mice
Erin Garrigan, Nicole S Belkin, Federica Seydel, et al.
Pediatric Diabetes
|
December 6, 2003
Aberrant monocyte prostaglandin synthase 2 (PGS2) expression in type 1 diabetes before and after disease onset
S A Litherland, J X She, D Schatz, et al.
Eclinicalmedicine
|
July 26, 2021
N-acetylcysteine (NAC) for methamphetamine dependence: A randomised controlled trial
Rebecca McKetin, Olivia M Dean, Alyna Turner, et al.
Biorxiv : the Preprint Server for Biology
|
October 9, 2023
Replenishing Age-Related Decline of IRAK-M Expression in Retinal Pigment Epithelium Attenuates Outer Retinal Degeneration
Jian Liu, David A Copland, Alison J Clare, et al.
BMJ Open
|
May 27, 2026
SAGE (safer analgesia): a protocol for a pragmatic cluster randomised controlled trial to reduce the use of high-risk medicines in people with chronic back and/or neck pain
Christina Abdel Shaheed, Andrew J McLachlan, Stephanie Mathieson, et al.
Science Translational Medicine
|
June 5, 2024
Replenishing IRAK-M expression in retinal pigment epithelium attenuates outer retinal degeneration
Jian Liu, David A Copland, Alison J Clare, et al.
Trials
|
June 21, 2024
A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial
Rebecca McKetin, Tayla J Degan, Lucy Saunders, et al.
JAMA Psychiatry
|
April 1, 2026
Mirtazapine for Methamphetamine Use Disorder: A Randomized Clinical Trial
Rebecca McKetin, Steven Shoptaw, Lucy Saunders, et al.
Page
of 25
Search research articles
Search
Showing results (231-240 of 241) with videos related to
Sort By:
Page
of 25
Clinical Pharmacology and Therapeutics
|
May 28, 2020
How to Transition from Single-Gene Pharmacogenetic Testing to Preemptive Panel-Based Testing: A Tutorial
Richard J Marrero, Emily J Cicali, Meghan J Arwood, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
January 24, 2019
CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trial
D Max Smith, Kristin W Weitzel, Amanda R Elsey, et al.
Genetics & Epigenetics
|
October 30, 2015
Csf2 and Ptgs2 Epigenetic Dysregulation in Diabetes-prone Bicongenic B6.NODC11bxC1tb Mice
Erin Garrigan, Nicole S Belkin, Federica Seydel, et al.
Pediatric Diabetes
|
December 6, 2003
Aberrant monocyte prostaglandin synthase 2 (PGS2) expression in type 1 diabetes before and after disease onset
S A Litherland, J X She, D Schatz, et al.
Eclinicalmedicine
|
July 26, 2021
N-acetylcysteine (NAC) for methamphetamine dependence: A randomised controlled trial
Rebecca McKetin, Olivia M Dean, Alyna Turner, et al.
Biorxiv : the Preprint Server for Biology
|
October 9, 2023
Replenishing Age-Related Decline of IRAK-M Expression in Retinal Pigment Epithelium Attenuates Outer Retinal Degeneration
Jian Liu, David A Copland, Alison J Clare, et al.
BMJ Open
|
May 27, 2026
SAGE (safer analgesia): a protocol for a pragmatic cluster randomised controlled trial to reduce the use of high-risk medicines in people with chronic back and/or neck pain
Christina Abdel Shaheed, Andrew J McLachlan, Stephanie Mathieson, et al.
Science Translational Medicine
|
June 5, 2024
Replenishing IRAK-M expression in retinal pigment epithelium attenuates outer retinal degeneration
Jian Liu, David A Copland, Alison J Clare, et al.
Trials
|
June 21, 2024
A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial
Rebecca McKetin, Tayla J Degan, Lucy Saunders, et al.
JAMA Psychiatry
|
April 1, 2026
Mirtazapine for Methamphetamine Use Disorder: A Randomized Clinical Trial
Rebecca McKetin, Steven Shoptaw, Lucy Saunders, et al.
Page
of 25